RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Cell/gene therapies are on the ascendant these days, with several companies in clinical trials for Parkinson's, ALS, Spinal Cord Injury. Having said that, I am surprised too--if I was really curious, and I'm not quite that interested, I'd look up how many shares Adams owned of Sepracor when it was taken out at a high premium by Dainippon, and how many shares he owned of Inspire when Merck bought them out at a premium. He has a track record of dressing companies up for sale, and probably made a lot of money in each deal: he could probably provide capital as well, since Neurologix only has a quarter's worth left.

Anticipating the 'why doesn't Cortex bring in someone like that?'question--there may be several components (does he have connections to the Neurologix board??) but at the very least, during the current news cycle, Ampakines are seen as old news, gene therapies have regained cachet they'd lost for some time.

If Cortex is still around in a couple of years, it is possible the cycle could turn the other way. But at the moment, in the CNS world, they seem to be perceived as an old story. In the cardio/CSA world? I don't know how they are perceived, but it wouldnt be as old news.

NeuroInvestment